SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesmarket

095700 (095700) News

Follow 095700 (095700) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol 095700 Asset market Sector Markets 90 days 1 Updated Sep 15, 2026, 09:16 AM UTC Open live news feed
L Genexine’s GX-BP1 (SOX2 bioPROTAC) Suppresses Tumor Regrowth despite Osimertinib and Dato-DXd Combination and Achieves 6/6 Complete Responses in Triple Combination Genexine, Inc. (KOSDAQ: 095700) announced that Jaehyun Choi, Ph.D., CEO and Head of R&D, presented new preclinical data for GX-BP1, the company’s SOX2-targeting bioPROTAC, at the 2026 World Conference on Lung Cancer (WCL NEWS | Sep 15, 2026, 09:16 AM UTC